Define a "small virtual" Pharmaceutical or biotechnology company
Discuss specific hurdles faced by small, virtual companies and their impact on outsourcing and partnerships
Analyze Inadequate executions of the trial
Assess Training and implementation
Discuss strategies to maximize effectiveness of partnering relationships from the company and partner perspectives
Discuss reasons for inadequate funding
What questions have arisen in your practice for which you need answers/strategies that you can implement?
Are you interested in basic, intermediate or advanced level trainings?
What barriers might you have that would interfere with implementation of new information learned from this training?
How can this training (the overall meeting) be improved to better impact competence, performance and/or patient/client outcomes?
Additional comments: